T1	Line 0 368	1. High risk profiles for ischemic adverse events such as A. ST-segment elevation myocardial infarction (STEMI) B. Patients with cardiogenic shock or concomitant severe decompensated heart failure C. Myocardial infarction or stent thrombosis in spite of the maintenance of antiplatelet therapy D. Restenosis in stented segments or previous sites of balloon angioplasty
T2	Line 369 506	2. Patients who cannot follow allocated DAPT schedule due to the planned surgery or elective procedure within 3 months after the stenting
T3	Line 507 622	3. Recent history of major surgery or evident events of gastrointestinal bleeding within 1 month from the procedure
T4	Line 623 699	4. Patients on anticoagulation therapy with warfarin or other anticoagulants
T5	Line 700 793	5. Life expectancy less than 1 year (such as malignancies or other chronic systemic diseases)
T6	Line 794 811	6. Pregnant women
T7	Line 812 964	7. Past history of allergy or other contraindications for the following medications/materials: aspirin, clopidogrel, heparin, cobalt chromium, sirolimus
T8	Condition 26 49	ischemic adverse events
T9	Condition 3 21	High risk profiles
R1	AND Arg1:T9 Arg2:T8	
T10	Condition 61 111	ST-segment elevation myocardial infarction (STEMI)
T11	Condition 129 146	cardiogenic shock
T12	Condition 183 196	heart failure
T13	Qualifier 162 168	severe
T14	Qualifier 169 182	decompensated
R2	Has_qualifier Arg1:T12 Arg2:T14	
R3	Has_qualifier Arg1:T12 Arg2:T13	
T15	Scope 58 368	A. ST-segment elevation myocardial infarction (STEMI) B. Patients with cardiogenic shock or concomitant severe decompensated heart failure C. Myocardial infarction or stent thrombosis in spite of the maintenance of antiplatelet therapy D. Restenosis in stented segments or previous sites of balloon angioplasty
T16	Scope 3 49	High risk profiles for ischemic adverse events
R4	Subsumes Arg1:T16 Arg2:T15	
T17	Condition 200 221	Myocardial infarction
T18	Condition 225 241	stent thrombosis
T19	Drug 273 293	antiplatelet therapy
*	OR T18 T17
T20	Scope 200 241	Myocardial infarction or stent thrombosis
R5	AND Arg1:T20 Arg2:T19	
T21	Scope 197 293	C. Myocardial infarction or stent thrombosis in spite of the maintenance of antiplatelet therapy
T22	Condition 297 307	Restenosis
*	OR T20 T22 T12 T11 T10
T23	Mood 434 441	planned
T24	Procedure 442 449	surgery
T25	Qualifier 453 461	elective
T26	Procedure 462 471	procedure
R6	Has_qualifier Arg1:T26 Arg2:T25	
*	OR T26 T24
T27	Scope 442 471	surgery or elective procedure
R7	Has_mood Arg1:T27 Arg2:T23	
T28	Temporal 472 506	within 3 months after the stenting
R8	Has_temporal Arg1:T27 Arg2:T28	
T29	Condition 385 422	cannot follow allocated DAPT schedule
R9	Has_scope Arg1:T29 Arg2:T27	
T30	Procedure 528 541	major surgery
T31	Condition 553 588	events of gastrointestinal bleeding
T32	Temporal 589 622	within 1 month from the procedure
*	OR T31 T30
T33	Scope 528 588	major surgery or evident events of gastrointestinal bleeding
R10	Has_temporal Arg1:T33 Arg2:T32	
T34	Procedure 638 661	anticoagulation therapy
T35	Drug 667 675	warfarin
T36	Qualifier 679 684	other
T37	Drug 685 699	anticoagulants
R11	Has_qualifier Arg1:T37 Arg2:T36	
*	OR T35 T37
T38	Scope 667 699	warfarin or other anticoagulants
R12	Has_scope Arg1:T34 Arg2:T38	
T39	Observation 703 718	Life expectancy
T40	Value 719 735	less than 1 year
R13	Has_value Arg1:T39 Arg2:T40	
T41	Condition 745 757	malignancies
T42	Condition 767 792	chronic systemic diseases
T43	Qualifier 761 766	other
R14	Has_qualifier Arg1:T42 Arg2:T43	
*	OR T42 T41
T44	Scope 745 792	malignancies or other chronic systemic diseases
T45	Scope 703 735	Life expectancy less than 1 year
R15	Subsumes Arg1:T45 Arg2:T44	
T46	Condition 797 805	Pregnant
T47	Person 806 811	women
A1	Optional T47
R16	AND Arg1:T47 Arg2:T46	
T48	Condition 831 838	allergy
T49	Condition 848 865	contraindications
T50	Qualifier 842 847	other
R17	Has_qualifier Arg1:T49 Arg2:T50	
R18	AND Arg1:T49 Arg2:T48	
T51	Drug 907 914	aspirin
T52	Drug 916 927	clopidogrel
T53	Drug 929 936	heparin
T54	Drug 938 953	cobalt chromium
T55	Drug 955 964	sirolimus
*	OR T55 T54 T53 T52 T51
T56	Scope 907 964	aspirin, clopidogrel, heparin, cobalt chromium, sirolimus
T57	Scope 831 865	allergy or other contraindications
R19	Has_scope Arg1:T57 Arg2:T56	
